NCT06331819 Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
| NCT ID | NCT06331819 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jordan Collaborating Cardiology Group |
| Condition | Obstructive Sleep Apnea |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-03-10 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-03-10 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective cohort study is to study patients referred for sleep study by in-lab polysomnography in the Jordan University Hospital and the Jordan Hospital or with an at-home sleep study kit. The main aims are: * To prospectively obtain demographic and clinical information of patients referred for a sleep study. * To determine the diagnostic value of facial discoloration as potential marker for obstructive sleep apnea to increase detection rate for the condition. * To establish a correlation between obstructive sleep apnea and vasovagal symptoms with resulting increased smoking tendency and study the effect of treatment on the disorders. * To determine the association between timing of appearance of obstructive sleep apnea symptoms and initiation of smoking.
Eligibility Criteria
Inclusion Criteria: * Patients within age limit who agree to participate and sign the consent form. Exclusion Criteria: * Patients with prior diagnosis of obstructive sleep apnea by sleep study.
Contact & Investigator
Rand M Zaqqa
PRINCIPAL INVESTIGATOR
Jordan University Hospital
Frequently Asked Questions
Who can join the NCT06331819 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06331819 currently recruiting?
Yes, NCT06331819 is actively recruiting participants. Contact the research team at rand.zaqqa@outlook.com for enrollment information.
Where is the NCT06331819 trial being conducted?
This trial is being conducted at Amman, Jordan.
Who is sponsoring the NCT06331819 clinical trial?
NCT06331819 is sponsored by Jordan Collaborating Cardiology Group. The principal investigator is Rand M Zaqqa at Jordan University Hospital. The trial plans to enroll 200 participants.